ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

Choosing the Best HCC Treatment Based on Patient and Disease Stage

Integrity CE

M. Pishvaian, R. Finn, R. Salem, A. Singal

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Expert Panel on Sequencing Treatments in HCC

Integrity CE

M. Pishvaian, R. Finn, A. Singal, R. Salem

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

SoC and Future Perspectives in Hepatocellular Cancer

Arndt Vogel

2L Systemic Therapy for Unresectable HCC

Lorenza Rimassa

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES…

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

Optimizing Therapy Selection for Frontline Treatment of Advanced HCC

Angelo Pirozzi

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Johns Hopkins

M. Baretti

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of …

Insights from 2024 ESMO GI Annual Meeting

S. L. Chan

ESMO 2024 Summary: HCC Treatment Highlights

COR2ED The Heart of Medical Education

R. Finn